NeoMTA Plus, ProRoot MTA and Biodentine useful as reparative biomaterials: Study

Written By : Dr. Nandita Mohan |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2021-11-16T09:00:38+05:30 | Updated On 16 Nov 2021 9:00 AM IST

Researchers from a recent study have observed that NeoMTA Plus, ProRoot MTA and Biodentine materials extracts are not cytotoxic and do not induce apoptosis in the human dental pulp stem cells (hDPSCs).

The study is published in the Journal of Dental Sciences.

Dental pulp stem cells (DPSCs) play a crucial role in the tissue healing process through odontoblast like cell differentiation.

Calcium silicate cements, such as Mineral trioxide aggregate (MTA) and Biodentine, have a wide and successful range of various clinical dental applications. Tricalcium silicate cements are called dental biomaterials because of their physicochemical and biocompatibility.

NeoMTA Plus was developed with similar properties to MTA. It is stated that NeoMTA Plus does not cause discoloration in dental tissues, it has sufficient radiopacity and hydration with MTA and it shows the production of calcium hydroxide required to induce mineralized tissue formation.

Hence, Sinem Birant and associates from the Istanbul University-Cerrahpasa, Faculty of Dentistry, Department of Pedodontics, Istanbul Turkey conducted the present study to evaluate the biocompatibility and compare the potential invitro cytotoxic effects of NeoMTA Plus, ProRootMTA and Biodentine on human dental pulp stem cells (hDPSCs).

To assess the effects of NeoMTA Plus, ProRoot MTA and Biodentine extracts at 1st, 3rd and 7th d on hDPCs, cell populations was determined by flow cytometry using an Annexin V detection kit. The data were analyzed statistically using the Kruskal–Wallis test. A p < 0.05 was considered as statistically significant.

The results showed that all groups showed cell viability similar to that of the control group on 1st, 3rd and 7th d. Although Biodentine exhibited higher cell viability rates than the other material groups, no statistically significant differences were noted between the sampled days (p > 0.05).

Therefore, the authors concluded that "all materials extracts are not cytotoxic and do not induce apoptosis in the hDPSCs. These results suggest that all the tested materials can lead to positive outcomes when used as reparative biomaterials."

NeoMTA PlusProRoot MTABiodentinereparativeBiomaterialsJournal of Dental Sciences

Source : Journal of Dental Sciences

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751